Department of Translational Medicine
1291 – 1300 of 8627
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Variable proportions of phylogenetic clustering and low levels of antiviral drug resistance among the major hbv sub-genotypes in the middle east and North Africa
(
- Contribution to journal › Article
-
Mark
Urinary diversions for benign and oncologic indications: what did we learn about short term complications in the last 24 months?
(
- Contribution to journal › Article
-
Mark
Complex Involvement of Interleukin-26 in Bacterial Lung Infection
(
- Contribution to journal › Article
-
Mark
Advanced Bladder Cancer. Aspects of Diagnosis and Treatment.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood
(
- Contribution to journal › Article
-
Mark
Artificial intelligence detection of missed cancers at digital mammography that were detected at digital breast tomosynthesis
(
- Contribution to journal › Article
-
Mark
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer : recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
(
- Contribution to journal › Scientific review
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
(
- Contribution to journal › Debate/Note/Editorial